← SynDRA
VU0238429
SynDRA canonical compound SYN1950582 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CHRM5 |
| Mechanism of action | acetylcholine receptor allosteric modulator |
All known targets
Mechanisms of action (all sources)
- acetylcholine receptor allosteric modulator
- CHRM5 INHIBITOR
Cross-references
Synonyms
- VU-0238429
- 1-(4-METHOXYBENZYL)-5-TRIFLUOROMETHOXYISATIN
- CHEMBL466253
- 1-[(4-Methoxyphenyl)methyl]-5-(trifluoromethoxy)-1H-indole-2,3-dione
- GTPL3257
- CTK8E8884
- DTXSID40655290
- MolPort-023-276-878
- cid_42633508
- ML129
- MFCD16618396
- BDBM50258656
- ZINC40875741
- AKOS024457724
- API0008325
- HY-12157
- KB-81463
- RT-017613
- B7448
- CS-0003122
- VU0238429-1
- VU0238429, solubility: >=20 mg/mL in DMSO
- J-003368
- 1-(4-methoxybenzyl)-5-(trifluoromethoxy)indoline-2,3-dione
- ZH1ZWF5Q3P
- 1H-Indole-2,3-dione, 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethoxy)-
- ML-129
- 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethoxy)-2,3-dihydro-1H-indole-2,3-dione
- 1-(4-Methoxy-benzyl)-5-trifluoromethoxy-1H-indole-2,3-dione
- 1-((4-Methoxyphenyl)methyl)-5-(trifluoromethoxy)-1H-indole-2,3-dione
- 1H-Indole-2,3-dione, 1-((4-methoxyphenyl)methyl)-5-(trifluoromethoxy)-
- 1-[(4-methoxyphenyl)methyl]-5-(trifluoromethoxy)indole-2,3-dione
- UNII-ZH1ZWF5Q3P
- HMS3414C19
- HMS3678C19
- BCP33882
- EX-A4042
- s2646
- AC-36485
Look up VU0238429 in the interactive SynDRA portal →